Platycodin D-mediated METTL16 downregulation promotes docetaxel treatment of prostate cancer by regulating ferroptosis. Sun C, Sun X, Chen Y, Wu Y, et al. BMC Cancer 2025;25:1042.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun C, Sun X, Chen Y, Wu Y, et al. Platycodin D-mediated METTL16 downregulation promotes docetaxel treatment of prostate cancer by regulating ferroptosis. BMC Cancer 2025;25:1042.
PMID: 40597047